CWCan Wu

Can Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Can Wu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Chen

    Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital, Wuhan University, Wuhan, China

    2 shared publications
  • Gang Li

    Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan 430071, China

    2 shared publications
  • Guanyi Wang

    Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital, Wuhan University, Wuhan, China

    2 shared publications
  • Sheng Li

    Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China

    2 shared publications
  • Ziyu Jiang

    Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital, Wuhan University, Wuhan, China

    2 shared publications

Latest Publications

  • Open Access

    Efficient Use of Biological Data in the Web 3.0 Era by Applying Nonfungible Token Technology

    by Guanyi Wang, Chen Chen, Ziyu Jiang, Gang Li, Can Wu, Sheng Li

    CryptoKitties, a trendy game on Ethereum that is an open-source public blockchain platform with a smart contract function, brought nonfungible tokens (NFTs) into the public eye in 2017. NFTs are popular because of their nonfungible properties and their unique and irreplaceable nature in the real world. The embryonic form of NFTs can be traced back to a P2P network protocol improved based on Bitcoin in 2012 that can realize decentralized digital asset transactions. NFTs have recently gained much attention and have shown an unprecedented explosive growth trend. Herein, the concept of digital asset NFTs is introduced into the medical and health field to conduct a subversive discussion on biobank operations. By converting biomedical data into NFTs, the collection and circulation of samples can be accelerated, and the transformation of resources can be promoted. In conclusion, the biobank can achieve sustainable development through “decentralization.”


  • Open Access

    Efficient Use of Biological Data in the Web 3.0 Era by Applying Nonfungible Token Technology (Preprint)

    by Guanyi Wang, Chen Chen, Ziyu Jiang, Gang Li, Can Wu, Sheng Li

    UNSTRUCTURED CryptoKitties, a trendy game on Ethereum that is an open-source public blockchain platform with a smart contract function, brought nonfungible tokens (NFTs) into the public eye in 2017. NFTs are popular because of their nonfungible properties and their unique and irreplaceable nature in the real world. The embryonic form of NFTs can be traced back to a P2P network protocol improved based on Bitcoin in 2012 that can realize decentralized digital asset transactions. NFTs have recently gained much attention and have shown an unprecedented explosive growth trend. Herein, the concept of digital asset NFTs is introduced into the medical and health field to conduct a subversive discussion on biobank operations. By converting biomedical data into NFTs, the collection and circulation of samples can be accelerated, and the transformation of resources can be promoted. In conclusion, the biobank can achieve sustainable development through “decentralization.”